|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.10 USD | +2.53% |
|
+2.26% | +43.60% |
| 10/07 | Insmed Insider Sold Shares Worth $5,537,460, According to a Recent SEC Filing | MT |
| 07/07 | RBC Lifts Price Target on Insmed to $108 From $106, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INSMED INCORPORATED | Bio Therapeutic Drugs | +2.56% | +2.26% | +43.60% | +28.70% | +276.24% | 1.84TCr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- INSM Stock
- Charts Insmed Incorporated
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition